Sonder Futures
ActiveFiled to raiseSan Francisco, CAHealthcare, BiotechnologyLast fund filed July 2024
5 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Sonder Futures II OS | July 2024 | $8.5M | $8.5M | 5 |
| Sonder Futures IIFiled to raise in 2023, with no closing reported yet. | 2023 | $225M | $0 | 0 |
| Sonder Futures I Partners Fund | September 2020 | $15M | $15M | 2 |
| Sonder Futures IFiled to raise in 2020, with no closing reported yet. | 2020 | $80M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
6 partners are named across this firm’s filings, 5 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Frederic Moll | Active | Medical devices | 15 | 4 |
| Kate Garrett | Slowing | Medical devices, Biotech & pharma | 3 | 1 |
| Andy McGibbon | Quiet | Medical devices | 2 | 0 |
| Colby WoodNot on the current fund | Quiet | Medical devices | 2 | 0 |
| Jay Watkins | Quiet | Medical devices, Biotech & pharma, Digital health | 9 | 0 |
| M. Wood | Quiet | Medical devices | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Sonder Futures’s own portfolio companies, based on 22 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Sonder Futures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Lux Capital | 2 | AURIS SURGICAL ROBOTICS, Avail Medsystems |
| Aperture | 1 | Venus Concept |
| Battery Ventures | 1 | EndoQuest Robotics |
| Healthquest Partners | 1 | Venus Concept |
| Imaginary Venture Capital | 1 | SYNERGEYES |
| Longitude 103.8 East | 1 | Venus Concept |
| Longitude Capital | 1 | Venus Concept |
| Longitude Prime | 1 | Venus Concept |
| Mithril | 1 | AURIS SURGICAL ROBOTICS |
| Sofinnova Venture Partners | 1 | Venus Concept |
| Vivo Innovation | 1 | PROCEPT BioRobotics |
A shared board seat: a company where filings name a Sonder Futures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.